Jump Financial, LLC Nurix Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	BUY	$4.25 - $10.71 $13,736 - $34,614	3,232 Added 26.71%	15,332 $158,000
Q4 2023 Feb 07, 2024	BUY	$4.25 - $10.71 $65,161 - $164,205	15,332 New	15,332 $158,000
Q1 2023 Oct 21, 2024	BUY	$8.56 - $13.26 $103,576 - $160,446	12,100 New	12,100 $107,000
Q1 2023 May 03, 2023	SELL	$8.56 - $13.26 $112,760 - $174,673	-13,173 Reduced 52.12%	12,100 $107,000
Q4 2022 Feb 13, 2023	SELL	$9.86 - $14.59 $182,676 - $270,308	-18,527 Reduced 42.3%	25,273 $277,000
Q3 2022 Nov 07, 2022	BUY	$12.33 - $19.81 $71,514 - $114,897	5,800 Added 15.26%	43,800 $571,000
Q2 2022 Aug 09, 2022	BUY	$7.88 - $14.82 $45,995 - $86,504	5,837 Added 18.15%	38,000 $481,000
Q1 2022 May 12, 2022	BUY	$12.94 - $29.65 $416,189 - $953,632	32,163 New	32,163 $451,000

181

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $923M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.